Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 8;60(11):1830-1838.
doi: 10.1515/cclm-2022-0646. Print 2022 Oct 26.

Serum GFAP - reference interval and preanalytical properties in Danish adults

Lea Tybirk  1 , Claus Vinter Bødker Hviid  1   2   3 , Cindy Soendersoe Knudsen  1 , Tina Parkner  1   3
Affiliations

Serum GFAP - reference interval and preanalytical properties in Danish adults

Lea Tybirk et al. Clin Chem Lab Med. .

Abstract

Objectives: Glial fibrillary acidic protein (GFAP) is a promising biomarker that could potentially contribute to diagnosis and prognosis in neurological diseases. The biomarker is approaching clinical use but the reference interval for serum GFAP remains to be established, and knowledge about the effect of preanalytical factors is also limited.

Methods: Serum samples from 371 apparently healthy reference subjects, 21-90 years of age, were measured by a single-molecule array (Simoa) assay. Continuous reference intervals were modelled using non-parametric quantile regression and compared with traditional age-partitioned non-parametric reference intervals established according to the Clinical and Laboratory Standards Institute (CLSI) guideline C28-A3. The following preanalytical conditions were also examined: stability in whole blood at room temperature (RT), stability in serum at RT and -20 °C, repeated freeze-thaw cycles, and haemolysis.

Results: The continuous reference interval showed good overall agreement with the traditional age-partitioned reference intervals of 25-136 ng/L, 34-242 ng/L, and 5-438 ng/L for the age groups 20-39, 40-64, and 65-90 years, respectively. Both types of reference intervals showed increasing levels and variability of serum GFAP with age. In the preanalytical tests, the mean changes from baseline were 2.3% (95% CI: -2.4%, 6.9%) in whole blood after 9 h at RT, 3.1% (95% CI: -4.5%, 10.7%) in serum after 7 days at RT, 10.4% (95% CI: -6.0%, 26.8%) in serum after 133 days at -20 °C, and 10.4% (95% CI: 9.5%, 11.4%) after three freeze-thaw cycles.

Conclusions: The study establishes age-dependent reference ranges for serum GFAP in adults and demonstrates overall good stability of the biomarker.

Keywords: glial fibrillary acidic protein (GFAP); preanalytical; reference range; serum; stability.

PubMed Disclaimer

References

    1. Abdelhak, A, Foschi, M, Abu-Rumeileh, S, Yue, JK, D’Anna, L, Huss, A, et al.. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol 2022;18:158–72. https://doi.org/10.1038/s41582-021-00616-3.
    1. Huebschmann, NA, Luoto, TM, Karr, JE, Berghem, K, Blennow, K, Zetterberg, H, et al.. Comparing glial fibrillary acidic protein (GFAP) in serum and plasma following mild traumatic brain injury in older adults. Front Neurol 2020;11:1054. https://doi.org/10.3389/fneur.2020.01054.
    1. Korley, FK, Yue, JK, Wilson, DH, Hrusovsky, K, Diaz-Arrastia, R, Ferguson, AR, et al.. Performance evaluation of a multiplex assay for simultaneous detection of four clinically relevant traumatic brain injury biomarkers. J Neurotrauma 2019;36:182–7. https://doi.org/10.1089/neu.2017.5623.
    1. Okonkwo, DO, Puffer, RC, Puccio, AM, Yuh, EL, Yue, JK, Diaz-Arrastia, R, et al.. Point-of-care platform blood biomarker testing of glial fibrillary acidic protein versus S100 calcium-binding protein B for prediction of traumatic brain injuries: a transforming research and clinical knowledge in traumatic brain injury study. J Neurotrauma 2020;37:2460–7. https://doi.org/10.1089/neu.2020.7140.
    1. Czeiter, E, Amrein, K, Gravesteijn, BY, Lecky, F, Menon, DK, Mondello, S, et al.. Blood biomarkers on admission in acute traumatic brain injury: relations to severity, CT findings and care path in the CENTER-TBI study. EBioMedicine 2020;56:102785. https://doi.org/10.1016/j.ebiom.2020.102785.